Skip to main content
MarketsSingle-sourceMediumDeveloping
5.1

Sangamo Therapeutics files for bankruptcy and enters material definitive agreement

Sangamo Therapeutics has filed an 8-K disclosing entry into a material definitive agreement alongside a bankruptcy or receivership filing. The specific terms of the restructuring or liquidation remain unclear, signaling significant financial distress for the biotechnology firm.

SEC EDGAR 8-K Filingsabout 2 hours agoUSengCredibility 10%View source

Score Breakdown

Mosaic Score5.1
Confidence0.9
Significance0.5
Source credibility0.1

Intelligence Tags

Entities

country
Source

Related signals

8 found